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Abstract
Background: In 2007, Park et al. identified a novel serotype among Streptococcus pneumoniae serogroup 6 which
they named serotype 6C. The aim of this study was to evaluate with the Neufeld test a novel S. pneumoniae
serotype 6C type specific polyclonal antiserum. In addition, serotype 6C isolates found in Denmark in 2007 and
2008 as well as eight old original serotype 6A isolates were characterised.
Methods: In this study, 181 clinical Streptococcus pneumoniae isolates from Denmark 2007 and 2008 were
examined; 96 isolates had previously been typed as serotype 6A and 85 as serotype 6B. In addition, eight older
isolates from 1952 to 1987, earlier serotyped as 6A, were examined. Serotype 6C isolates were identified by PCR
and serotyping with the Neufeld test using the novel type specific polyclonal antiserum, factor antiserum 6 d, in
addition to factor antisera 6b, 6b* (absorbed free for cross-reactions to serotype 6C) and 6c. All antisera are
commercially available and antiserum 6b obtained from the supplier after 1 January 2009 is antiserum 6b*. All
serotype 6C isolates were further characterised using multi-locus sequence typing.
Results: When retesting all 96 original serotype 6A isolates by PCR and the Neufeld test, 29.6% (24 of 81) of the
invasive isolates in Denmark from 2007 and 2008 were recognised as serotype 6C. In addition, three of eight old
isolates originally serotyped as 6A were identified to be serotype 6C. The oldest serotype 6C isolate was from 1962.
The serotype 6C isolates belonged to eleven different sequence types (ST) and nine clonal complexes (CC), ST1692
(CC395), ST386 (CC386) and ST481 (CC460) were the predominant types.
Conclusions: We tested a novel polyclonal antiserum 6 d, as well as modified antiserum 6b*, provided a scheme
for the serotyping of S. pneumoniae serogroup 6 using the Neufeld test and compared the serotyping method
with PCR based methods. The two types of methods provided the same results. In future, it will, therefore, be
possible to test also serotype 6C in accordance to the standard method for serotyping of S. pneumoniae
recommended by WHO.
Among all invasive isolates from Denmark 2007 and 2008, serotype 6C constituted 29.6% of the original serotype
6A isolates. The serotype 6C isolates were found to be diverse belonging to a number of different STs and CCs of
which most have been observed in other countries previously. Serotype 6C is regarded as an “old” serotype being
present among S. pneumoniae isolates in Denmark for at least 48 years. The genetic diversity of serotype 6C iso-
lates and their genetic relationship to other serotypes suggested that serotype 6C strains may have arisen from
several different independent recombination events involving different parental strains such as serotypes 6A, 6B,
23F and 4.
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In 2007, Park et al. [1] identified a novel serotype
among Streptococcus pneumoniae serogroup 6 and
named it serotype 6C. This novel serotype was identified
by the use of monoclonal antibodies and verified by
sequencing of the capsule gene locus [1,2]. Interestingly,
serotype 6C was found among isolates that were origin-
ally identified as serotype 6A using the WHO recom-
mended standard serotyping method of S. pneumoniae,
the Neufeld test [3]. To our knowledge, it was the first
time a novel serotype was found among isolates that
were easily serotypeable. In the past, novel serotypes
were found among isolates that were non-serotypeable
with the available antisera or isolates that showed odd
combinations of specific reactions with the antisera.
The genetic difference between serotypes 6A and 6C is
the wciN gene [2] encoding a transferase resulting in an
altered composition of the polysaccharide capsule. This
gene may be used to distinguish serotype 6A from 6C
and as soon as the news concerning this novel serotype
was out, many laboratories started testing for serotype
6C using PCR [4-7]. Subsequently, serotype 6C has been
detected among invasive isolates [8] as well as non-inva-
sive [5] and carriage isolates [9] and to date serotype 6C
has been reported in the following countries: Canada, the
U.S., Mexico, Brazil, the Netherlands, Portugal, South
Africa, Korea, China and Australia [10,6,8,9,11]. These
countries represent most continents. Serotype 6C is,
therefore, not considered a rare serotype and it is
expected that it will be found in all parts of the world.
For that reason, it is of interest to be able to identify sero-
type 6C using the Neufeld test and typespecific polyclo-
nal antisera as is the case for the 90 other serotypes.
The aim of this study was to evaluate with the Neu-
feld test a novel S. pneumoniae serotype 6C type specific
polyclonal antiserum raised in rabbits. This novel anti-
serum has been commercially available since 1 January
2009. In addition, serotype 6C isolates found in Den-
mark in 2007 and 2008 as well as eight older serotype
6A isolates were characterised.
Methods
Bacterial isolates
In this study, 181 clinical Streptococcus pneumoniae iso-
lates (one isolate per case) from 2007 and 2008 were
examined. Of these isolates, 96 had previously been
typed as serotype 6A and 85 as serotype 6B. The isolates
were received in the reference laboratory from Danish
clinical microbiological laboratories. Ethical approval
was not needed for this study. The sample origin of the
isolates is shown in Table 1. In addition, eight older iso-
lates from the period 1952 to 1987, which had earlier
been serotyped as 6A were examined. As positive
controls, we used serotype 6C isolates identified in two
other countries, one isolate from the Netherlands (Peter
Hermans, Nijmegen, The Netherlands) and three iso-
lates from the U.S. (Michael Jacobs, Cleveland, Ohio).
Isolates were grown on 10% blood agar plates (SSI
Diagnostica, Hilleroed, Denmark) at 36°C in air with 5%
CO2 and stocks of isolates were stored at -80°C in beef
broth with 10% glycerol (SSI Diagnostica). Bacterial
chelex-solution lysates were used as DNA templates for
PCR.
All isolates were tested for susceptibility to antimicro-
bial agents as described in the DANMAP 2008 report
http://www.danmap.org.
PCR for identification of serotype 6C
For PCR1, primers 5106 (5-TACCATGCAGGGTG-
GAATGT) [2] and 3101 (5-CCATCCTTCGAGTATTGC)
[12] were used. For PCR2, primers 6A-N-6195 (5-
TTGGACAATCTGGAAAGATATTG) and 6A-N-7642
(5-GCTTTTTTAGCAGGCGACATAG) were used (num-
bers in the PCR2 primer names refers to the 5’annealing
site of the primer to sequence [GenBank: EF538714]).
PCR was performed using a 25 μl PCR mix with 12.5 μl
HotstarTaq Mastermix (Qiagen, Hamburg, Germany),
0.5 mM additional MgCl2, 0.2 μM of the relevant primers
and 2 μl DNA-template. The PCR programme used was;
15 min at 95°C, 35 cycles of 30 sec at 95°C, 30 sec at 50°C
(52°C for PCR2) and 90 sec at 72°C. The PCR was finalised
by 10 min at 72°C. The presence and quality of the PCR
fragments was tested by gel-electrophoresis on 2% E-gels
(Invitrogen A/S, Taastrup, Denmark).
Table 1 Overview of analysed S. pneumoniae serotype 6C
Serotype 6A%
(n)
6B
% (n)
6C
% (n)
Invasive isolates
blood 84.2 (48) 90.6 (58) 79.2 (19)
cerebrospinal fluid 14.0 (8) 6.3 (4) 16.7 (4)
other sterile site 1.8 (1) 3.1 (2) 4.2 (1)
Proportion of serogroup 6 39.3 (57) 44.1 (64) 16.6 (24)
6C of original 6A 29.6 (24 of 81)
Non-invasive isolates
eye 25.0 (3) 9.5 (2)
ear 33.3 (4) 38.1 (8) 100 (3)
other non-sterile site 41.7 (5) 52.4 (11)
Proportion of serogroup 6 33.3 (12) 58.3 (21) 8.3 (3)
6C of original 6A 20.0 (3 of 15)
All isolates
Proportion of serogroup 6 38.1 (69) 47.0 (85) 14.9 (27)
6C of original 6A 28.1 (27 of 96)
Analysed S. pneumoniae serotype 6C isolates compared to other serogroup 6
isolates from Denmark 2007 and 2008.
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serotype 6A and 1,25 kb from serotype 6C. PCR2
resulted in an 2,00 kb PCR fragment from serotype 6A
and an 1,80 kb fragment from serotype 6C.
Sequence determination of wciN
Excess primers and nucleotides in the solution contain-
ing the PCR fragments from PCR1 or PCR2 were inacti-
vated with ExoSap IT® as described by the manufacturer
(USB Corporation, Cleveland, USA) before sequencing.
Both strands of the PCR fragments were sequenced
using 0.2 μM of the relevant primers, BigDye Termina-
tor 3.1 Cycle Sequencing Kit (Applied Biosystems,
Foster City, USA) and an ABI-prisme 3100 Genetic
Analyzer (Applied Biosystems) as recommended by the
manufacturer.
Serotype determination and test of serotype 6C type
specific antisera
Serogroup determination was performed by agglutina-
tion test using Pneumotest Latex (SSI Diagnostica).
Briefly, a culture of each isolate was grown in serum
broth (SSI Diagnostica) overnight at 36°C in air with 5%
CO2.A na l i q u o to f1 0μl culture and 10 μl of latex sus-
pension were placed next to each other on a cardboard
reaction card, mixed and spread with a wooden tooth-
stick followed by rocking the card from side to side.
Each isolate was tested for reactions in all latex pools at
the same time. Positive reactions showed as clear agglu-
tination reactions within 10-20 sec. In the case of
serogroup 6, these were positive reactions in latex pool
B and Q. Serotype determination was performed with
the Neufeld test using S. pneumoniae type specific rabbit
antisera as recommended by the manufacturer (SSI
Diagnostica). In this case, the factor antisera used were
6b, 6b* (absorbed free for cross reactions to serotype
6C), 6c and the novel antiserum 6 d. Briefly, isolates
were grown on 10% blood agar plates overnight at 36°C
in air with 5% CO2. A small amount of bacteria from
the plate was suspended in an aliquot of 1-2 μl saline
placed on a microscope slide. Finally, 1-2 μlf a c t o ra n t i -
serum was added to the bacterium-saline suspension
with an 1 μl plastic inoculation needle. A glass cover
slip was placed on the mixture, a drop of immersion oil
added and the bacteria were inspected in a light micro-
scope with 100× magnification, phase-contrast and a
green filter. Each isolate was tested for reaction with all
factor antisera within the group at the same time.
A positive reaction was observed as a swelling of the bac-
terium and capsule, often agglutination also occurred.
Multi locus sequence typing (MLST)
Sequence types were determined as described at http://
spneumoniae.mlst.net/.
Data analysis
All sequences were analysed using the software BioNu-
merics (Applied Math, Sint-Martens-Latem, Belgium)
and sequence types identified with the information
provided at http://spneumoniae.mlst.net/. Clonal rela-
tionships of sequence types and predictions of founders
were analysed using the programme eBURST and the
complete MLST S. pneumoniae database at http://
spneumoniae.mlst.net/. Sequences of wciNw e r ec o m -
pared to the sequence of S. pneumoniae CHPA388
[GenBank: EF538714], sequence and amino acid num-
bers refer to that sequence.
Predictions of the protein secondary structure and the
amino acid accessibility was analysed using the pro-
gramme NetSurfP at http://www.cbs.dtu.dk/services/
NetSurfP/[13].
Results
Genetic identification of S. pneumoniae serotype 6C
isolates by PCR and sequencing of the wciN gene
Of all 96 original serotype 6A isolates from 2007 and
2008, 28.1% (n = 27) were tested to be serotype 6C by
both PCR1 and PCR2 described in Methods. The PCR
fragments from all isolates had the expected sizes and
were similar to those from the positive controls of sero-
type 6C isolates identified in two different countries.
The coding region of the wciN genes of all 27 PCR
detected 6C isolates were 100% identical among the iso-
lates. The genes showed 99.7% similarity to the wciN
gene of 6C [GenBank: EF538714] published by Park et al
2007 and 99.9% similarity to the four other published
sequences [GenBank: EF538716, EF538717, EF538715
and EF538718]. Compared to [GenBank: EF538714]
sequence, the nucleotide changes were T65A, C541A and
G677T. These changes did result in amino acid changes
of the WciN protein of F22Y, H181N and G226V, how-
ever, these changes did not alter the predictions of the
secondary structure and the amino acid accessibility ana-
lysed using the programme NetSurfP at http://www.cbs.
dtu.dk/services/NetSurfP/[13]. Using this programme,
amino acids 22 and 181 were most likely located in
alpha-helixes and amino acid 226 was most probably part
of a beta-strand; all three amino acids were predicted to
have low relative and absolute surface accessibility.
Test of S. pneumoniae serotype 6C type specific
polyclonal factor antiserum 6d
A novel type specific rabbit antiserum, named factor
antiserum 6 d, was tested in addition to the existing fac-
tor antisera 6b and 6c (Table 2) on all original serotypes
6A (n = 96) and 6B (85) isolates. Using the Neufeld test,
all serotype 6A isolates detected by PCR (n = 69)
showed positive and specific reactions with factor anti-
serum 6b. All serotype 6B isolates showed positive and
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6C isolates detected by PCR (n = 27) showed positive
and specific reaction with factor antiserum 6d; however,
in addition the serotype 6C isolates showed positive and
specific reactions with factor antiserum 6b. Therefore, a
modified factor antiserum 6b* absorbed free for cross
reactions to serotype 6C was produced and tested. This
antiserum should react specifically with serotype 6A but
not 6C. All serotypes 6A and 6C isolates were tested
and only serotype 6A isolates showed positive and speci-
fic reactions with factor antiserum 6b*. The resulting
serotyping scheme for serogroup 6, including the novel
factor antiserum 6 d and the modified antiserum 6b*, is
shown in Table 2.
Origin of serotype 6C isolates from 2007 and 2008
compared to other serogroup 6 isolates from Denmark
Upon retesting original serotype 6A isolates by PCR and
the Neufeld test, a proportion of 29.6% (24 of 81) of the
invasive isolates were serotype 6C (Table 1). These iso-
lates were from 23 patients with a mean age of 53.5 years
(range 0 to 92 years). In the same period of time from
the same geographic area, there were 56 serotype 6A and
62 serotype 6B isolates (Table 1). The serotype 6A iso-
lates were from patients with a mean age of 63.0 years
(range 0-91 years) and the serotype 6B isolates were from
patients with a mean age of 58.9 (range 0-99). Of the 6C
isolates, 48% were from females compared to 54% and
56% of serotype 6A and 6B isolates, respectively.
All invasive isolates were tested for susceptibility to the
two antimicrobial agents penicillin and erythromycin,
3.7% (n = 2) of serotype 6A, 6.5% (4) of serotype 6B and
4.3 (1) of serotype 6C were penicillin non-susceptible and
3.7% (n = 2) of serotype 6A, 9.7% (6) of serotype 6B and
13% (3) of serotype 6C were erythromycin resistant.
Clonal relation of serotype 6C isolates from Denmark
using multi locus sequence typing and antimicrobial
resistance pattern
Among all serotype 6C isolates, eight different sequence
types (STs) were found. The most prevalent STs were
ST1692 (n = 10), ST386 (6) and ST481 (5) (Table 3).
Most serotype 6C isolates were susceptible to the anti-
microbial agents tested and the non-susceptible isolates
were found to belong to two STs, ST386 and ST1379
(Table 3).
To evaluate the clonality of the serotype 6C isolates,
the founder of the clonal complex (CC) for each ST was
predicted using eBURST. The eight STs were found to
belong to seven different CCs (Table 3). By this method,
the serotype 6C isolates were found to be diverse.
Test of old serotype 6A isolates
Eight old isolates originally serotyped as serotype 6A
isolates were also tested. Three of them were typed to
be serotype 6C by the PCR methods and the Neufeld
test using the novel antisera. These three isolates were
from the years 1962, 1968, and 1987. The wciNg e n e
sequences were identical to the 6C isolates analysed
from 2007 to 2008, except for one of the isolates that
had a silent A7298G sequence change. The three iso-
lates all had different STs, ST3029, ST2185 and STnew1
belonging to three different CCs.
Discussion
This study compared two different methods to identify
serotype 6C S. pneumoniae; a phenotypic method, the
Neufeld test, based on the use of a novel polyclonal fac-
tor antiserum 6 d specific for serotype 6C and a genoty-
pic method based on PCR identification of the wciN
gene size difference between serotypes 6C and 6A. The
two methods provided the same results when testing 96
original serotype 6A isolates.
In addition to the novel antiserum 6 d, antiserum 6b
that showed specificity to both serotypes 6B and 6C was
altered to antiserum 6b* specific only to serotype 6B
and not to serotype 6C. These novel antisera together
with the known sera, should provide a sufficient panel
of antisera to be able to distinguish the currently known
serotypes of serogroup 6. All antisera are commercially
available and antiserum 6b obtained from the supplier
after 1 January 2009 is antiserum 6b*.
With this study we have shown that it was possible to
produce useful polyclonal antisera to be able to distin-
guish serotype 6C from the other serotypes within ser-
ogroup 6. The specificity of the factor serum 6 d was in
agreement with a recent validation study of this factor
serum performed by a different research group [14].
However, in that study, factor serum 6b and not 6b*
was used, which is why they observed serotype 6C to be
positive in both factor sera 6 d and 6b.
Very recently, a research group at CDC also showed
that it was possible to produce a specific polyclonal anti-
serum to distinguish serotype 6C from other serogroup
6 isolates following the same strategy as described here;
Table 2 Serotyping scheme for S. pneumoniae serogroup 6
Serotype Factor serum
6a 6b 6b* 6c 6d
6A xx x
6B xx
6C xx x
* absorbed with 6C
Serotyping scheme for S. pneumoniae serogroup 6 using the Neufeld test and
polyclonal factor antisera. Scheme for determining the serotype from the
pattern of positive reactions (x) between S. pneumoniae and type specific
polyclonal factor antisera.
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available [15].
One different phenotypic method based on monoclo-
nal antiserum identifying one specific epitope for the
identification of serotype 6C has been reported [1]. In
contrast, several genetically based methods based on the
identification of the wciN gene or sizes of specific PCR
fragments have been reported before [2,7,10,6].
With the discovery of serotype 6C, it became clear that
new technology, especially genetically based methods,
will change the number of known serotypes and the divi-
sion of groups into serotypes. It also became clear that it
is possible to use different methods for determining a
serotype. More methods provide possibilities for more
laboratories to perform serotype determination of iso-
lates, which is of high value when estimating and evaluat-
ing vaccine efficacies and vaccine failures. Different
methods for serotype determination will complement
each other, but all methods should be compared to one
international standardised reference method.
The international reference method and the WHO
recommended method for the serotyping of S. pneumo-
niae i st h eN e u f e l dt e s ta n dt h eu s eo ft y p es p e c i f i c
polyclonal antisera. With the production of the novel
antisera reported here, the Neufeld test can continue to
be the international reference method.
In 2007 and 2008, serotype 6C constituted 28.1% (27
of 96) of all original serotype 6A isolates received in the
Danish national reference laboratory. Among all invasive
isolates from the same time period, serotype 6C consti-
tuted 29.6% (24 of 81) of the original serotype 6A
isolates. This corresponds to 1.2% of all invasive
S. pneumoniae isolates and an incidence of 0.22 per
100,000 persons. This proportion is at the same level as
observed in other studies. Among isolates in Cleveland,
the U.S., from 1999 to 2007, 6C was observed to consti-
tute 26% of the previous serotype 6A isolates [5], among
invasive isolates from Brazil 1996 to 2007, 34% of pre-
vious serotype 6A isolates were found to be serotype 6C
[10], and among Australian invasive isolates previously
defined as serotype 6A, serotype 6C constituted 31% [7].
In contrast, serotype 6C was found to constitute only
5% of invasive isolates from children in South Africa in
2005-2006 [11] and only 0.3% among previously defined
6A carriage isolates from Dutch children in 2002 [4].
These studies showed that serotype 6C is widely spread
in the world and that it may constitute a higher or
lower proportion of the previously defined serotype 6A
isolates. The proportion of serotype 6C compared to the
other serotypes of serogroup 6 as well as the proportion
of serotype 6C compared to all serotypes is expected to
change with time and may change differently in different
areas with use of vaccines and antimicrobial agents as
factors that can provoke serotype distribution changes.
Such changes within serogroup 6 have already been
observed by the Active Bacterial Core Surveillance
Team in the U.S. They tested 16% invasive isolates of
original serotype 6A in 1999 to be serotype 6C; how-
ever, this changed to 65% and 69% in 2006 and 2007,
respectively. The change corresponded to a change in
the incidence of 6C invasive pneumococcal disease from
0.22 in 1999 to 0.58 in 2007 [6]. The dramatic change
Table 3 Sequence types (STs) and clonal complexes (CCs) of serotype 6C
2007-2008 is olates
Number of
isolates, n
ST CC
(founder)*
ST Antimicrobial resistance
profile (n)
ST has been found in serotypes
(countries)
#
CC has been found in serotypes
(countries)
#
10 1692 395 6A (UK, Switzerland) 6C (Portugal) 6A (UK, U.S.) 6C (Portugal, Italy)
6 386 386 PEN, ERY, CLI, TET (3) ERY, CLI,
TET (3)
6B (Portugal, Italy, Lebanon,
Germany)
6B (Portugal, Italy, Lebanon,
Germany)
5 481 460 6A (Finland) 6A (UK, U.S., France)
3 1379 1600 ERY (1) 6A (Sweden, U.S.) 6C (U.S., Australia) 6A (UK, U.S.)
1 398 473 6A (UK) 6A (UK, U.S., France,
Greece, Australia, Germany)
6B (Australia, Hungary)
6C (U.S.)
1 600 600 6A (Polan) 6C (Australia) 6A (Polan) 6C (Australia)
1 1714 395 6A (UK) 6C (Portugal) 23F (Norway) 6A (UK, U.S.) 6C (Portugal, Italy)
Old isolates
1 2185 2185 6A (Polan) 6C (Portugal) 6A (Polan) 6C (Portugal)
1 3029 3304 6A (U.S.) 4 (The Gambia)
1 new1
* in accordance to eBURST using the complete MLST database and a minimum similarity of six identical loci
#information in accordance to the http://www.mlst.net accessed 26. June 2010
Sequence types (STs) and clonal complexes (CCs) of serotype 6C isolates from Denmark in relation to those found previously in other countries.
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coccal vaccine in 2000 causing a decline in the incidence
of both serotype 6B and 6A cases, but an increase in the
proportion of serotype 6C cases [ref [6]]. This was prob-
ably observed, as the vaccine protects against invasive
infections with serotype 6B, but in addition the vaccine
has been shown to have a high level of cross-protection
against serotype 6A but not 6C [16]. Similar changes in
the distribution of serotypes within serogroup 6 can be
expected in Denmark in the future, as the vaccine was
introduced in 2007.
T h es a m p l eo r i g i n( s a m p l em a t e r i a l ,a g ea n ds e xo f
person) and antibiotic resistance level of serotype 6C
were quite similar to that found for the other serogroup
6 isolates. The proportion of antibiotic non-susceptible
6C was low compared to observations done in the U.S.
[5,6,17], but that may also change as observed by the
Active Bacterial Core Surveillance Team in the U.S.
after introduction of the vaccine [ref [6]].
Among all Danish serotype 6C isolates from 2007 and
2008, ten different STs belonging to nine CCs were
found and among the three old 6C isolates three differ-
ent STs and CCs were found. The serotype 6C isolates
in Denmark were, therefore, regarded as diverse. Except
for ST386 and STnew1, all of the serotype 6C STs had
been identified before in relation to serotype 6A from a
number of different countries (Table 3). It would be
interesting to re-analyse those serotype 6A isolates as
they may turn out to be serotype 6C with the current
knowledge. Thus ST481 and CC460 had only been
related to serotype 6A, they may, therefore, be true sero-
type 6A and not 6C if re-analysed. Four of the STs were
previously found in relation to serotype 6C, all from
geographically distant countries like Portugal, Australia
and the U.S. (Table 3). One ST, ST386 had previously
only been found in relation to serotype 6B in several
countries (Table 3). All of the CCs, except for CC386
and CC3304, had also been observed in a number of
countries in relation to serotypes 6A or 6C (Table 3).
CC386 had only been found in serotype 6B isolates and
in addition to 6A and 6C, CC473 had also been
observed in serotype 6B. CC395 had in addition to sero-
types 6A and 6C also been observed in serotype 23F
whereas CC3304 was previously only observed in sero-
type 4 (Table 3). All of these observations confirm the
suggestion by Carvalho et al. 2009 that serotype 6C
strains arose from independent recombination events.
Thus, in contrast to that study suggesting these involved
parental strains of serotypes 6A and 6C, this study sug-
gests that these events involve at least serotypes 6A, 6B
and possibly also serotypes 23F and 4 as parental strains.
With this study, it was also confirmed that serotype 6C
is an “old” serotype being present among S. pneumoniae
isolates in Denmark for at least 48 years. This time span
would allow the possibility that 6C strains may have
arisen from several different independent recombination
events involving different parental strains.
Conclusions
In this study we tested a novel polyclonal antiserum 6 d,
as well as a modified antiserum 6b*, provided a scheme
for serotyping of S. pneumoniae serogroup 6 using the
Neufeld test and compared the serotyping method with
PCR based methods. The two types of methods pro-
vided the same results. In the future, it will therefore be
possible to test also serotype 6C in accordance to the
WHO recommended standard method for serotyping of
S. pneumoniae.
Among all invasive isolates from Denmark 2007 and
2008, serotype 6C constituted 29.6% of the original sero-
type 6A invasive isolates. The serotype 6C isolates were
found to be diverse belonging to a number of different
STs and CCs of which most had been observed in other
countries previously. Serotype 6C is regarded as an “old”
serotype with the presence among S. pneumoniae iso-
lates in Denmark for at least 48 years. The genetic
diversity and relationship of the analysed 6C strains sug-
gest that serotype 6C strains may have arisen from sev-
eral different independent recombination events
involving different parental strains such as serotypes 6A,
6B, 23F and 4.
Acknowledgements
We thank the Danish departments of clinical microbiology for sending
isolates to the Neisseria and Streptococcus Reference laboratory. Staff in the
laboratories is thanked for their technical expertise and positive commitment
to the work. This work was part of the National Surveillance of severe
streptococcal infections funded by the Danish Ministry of the Interior and
Health. Part of this study was presented at the Europneumo meeting, Bern,
Switzerland, 2009.
Peter Hermans and Michael Jacobs are thanked for sharing 6C isolates.
Author details
1Neisseria and Streptococcus Reference Laboratory, Department for
Microbiological Surveillance and Research, Statens Serum Institut, Artillerivej,
Copenhagen, Denmark.
2SSI Diagnostica, Statens Serum Institut, Hilleroed,
Denmark.
Authors’ contributions
LL and MBK both contributed to this study by the conception and design of
the study, MBK produced and provided the novel antisera, LL managed all
laboratory work, collected data and did data analyses. LL drafted the
manuscript and both LL and MBK revised the manuscript critically. Both
authors have approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 6 April 2010 Accepted: 24 September 2010
Published: 24 September 2010
References
1. Park IH, Pritchard DG, Cartee R, Brandao A, Brandileone MC, Nahm MH:
Discovery of a new capsular serotype (6C) within serogroup 6 of
Streptococcus pneumoniae. J Clin Microbiol 2007, 45:1225-1233.
Lambertsen and Kerrn BMC Infectious Diseases 2010, 10:282
http://www.biomedcentral.com/1471-2334/10/282
Page 6 of 72. Park IH, Park S, Hollingshead SK, Nahm MH: Genetic basis for the new
pneumococcal serotype, 6C. Infect Immun 2007, 75:4482-4489.
3. O’Brien KL, Nohynek H: Report from a WHO Working Group: standard
method for detecting upper respiratory carriage of Streptococcus
pneumoniae. Pediatr Infect Dis J 2003, 22:e1-11.
4. Hermans PW, Blommaart M, Park IH, Nahm MH, Bogaert D: Low prevalence
of recently discovered pneumococcal serotype 6C isolates among
healthy Dutch children in the pre-vaccination era. Vaccine 2008,
26:449-450.
5. Jacobs MR, Good CE, Bajaksouzian S, Windau AR: Emergence of
Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup
15 in Cleveland, Ohio, in relation to introduction of the protein-
conjugated pneumococcal vaccine. Clin Infect Dis 2008, 47:1388-1395.
6. Carvalho MG, Pimenta FC, Gertz RE Jr, Joshi HH, Trujillo AA, Keys LE, et al:
PCR-based quantitation and clonal diversity of the current prevalent
invasive serogroup 6 pneumococcal serotype, 6C, in the United States in
1999 and 2006 to 2007. J Clin Microbiol 2009, 47:554-559.
7. Jin P, Xiao M, Kong F, Oftadeh S, Zhou F, Liu C, et al: Simple, accurate,
serotype-specific PCR assay to differentiate Streptococcus pneumoniae
serotypes 6A, 6B, and 6C. J Clin Microbiol 2009, 47:2470-2474.
8. Jacobs MR, Bajaksouzian S, Bonomo RA, Good CE, Windau AR, Hujer AM,
et al: Occurrence, distribution, and origins of Streptococcus pneumoniae
Serotype 6C, a recently recognized serotype. J Clin Microbiol 2009,
47:64-72.
9. Nunes S, Valente C, Sa-Leao R, de LH: Temporal trends and molecular
epidemiology of recently described serotype 6C of Streptococcus
pneumoniae. J Clin Microbiol 2009, 47:472-474.
10. Campos LC, Carvalho MG, Beall BW, Cordeiro SM, Takahashi D, Reis MG,
et al: Prevalence of Streptococcus pneumoniae serotype 6C among
invasive and carriage isolates in metropolitan Salvador, Brazil, from 1996
to 2007. Diagn Microbiol Infect Dis 2009, 65:112-115.
11. du PM, von GA, Madhi SA, Hattingh O, de GL, Klugman KP: Serotype 6C is
associated with penicillin-susceptible meningeal infections in human
immunodeficiency virus (HIV)-infected adults among invasive
pneumococcal isolates previously identified as serotype 6A in South
Africa. Int J Antimicrob Agents 2008, 32(Suppl 1):S66-S70.
12. Mavroidi A, Godoy D, Aanensen DM, Robinson DA, Hollingshead SK,
Spratt BG: Evolutionary genetics of the capsular locus of serogroup 6
pneumococci 1. J Bacteriol 2004, 186:8181-8192.
13. Petersen B, Petersen TN, Andersen P, Nielsen M, Lundegaard C: A generic
method for assignment of reliability scores applied to solvent
accessibility predictions. BMC Struct Biol 2009, 9:51.
14. Jacobs MR, Dagan R, Bajaksouzian S, Windau AR, Porat N: Validation of
factor 6 d antiserum for serotyping Streptococcus pneumoniae serotype
6C. J Clin Microbiol 2010, 48:1456.
15. Melnick N, Thompson TA, Beall BW: Serotype-specific typing antisera for
pneumococcal serogroup 6 serotypes 6A, 6B, and 6C. J Clin Microbiol
2010, 48:2311.
16. Park IH, Moore MR, Treanor JJ, Pelton SI, Pilishvili T, Beall B, Shelly MA,
Mahon BE, Nahm MH, Active Bacterial Core Surveillance Team: Differential
effects of pneumococcal vaccines against serotypes 6A and 6C. J Infect
Dis 2008, 198:1818.
17. Gertz RE Jr, Li Z, Pimenta FC, Jackson D, Juni BA, Lynfield R, Jorgensen JH,
Carvalho Mda G, Beall BW, Active Bacterial Core Surveillance Team:
Increased penicillin nonsusceptibility of nonvaccine-serotype invasive
pneumococci other than serotypes 19A and 6A in post-7-valent
conjugate vaccine era. J Infect Dis 2010, 201:770.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2334/10/282/prepub
doi:10.1186/1471-2334-10-282
Cite this article as: Lambertsen and Kerrn: Test of a Novel Streptococcus
pneumoniae Serotype 6C Type Specific Polyclonal Antiserum (Factor
Antiserum 6d) and Characterisation of Serotype 6C Isolates in Denmark.
BMC Infectious Diseases 2010 10:282.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Lambertsen and Kerrn BMC Infectious Diseases 2010, 10:282
http://www.biomedcentral.com/1471-2334/10/282
Page 7 of 7